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Abstract
Background: Desmoid tumors are slow growing deep fibromatoses with aggressive infiltration of
adjacent tissue but without any metastatic potential.
Case Presentation: We report on two female patients with desmoid tumor of the abdominal
wall who underwent primary resection. Both patients had a history of an earlier abdominal surgery.
Preoperative evaluation included abdominal ultrasound, magnetic resonance imaging and computed
tomography. The histology in both cases revealed a desmoid tumor.
Conclusion: Complete surgical resection is the first line management of this tumor entity.
Background
Desmoid tumors are benign myofibroblastic neoplasms
originating from the muscle aponeurosis and classified as
deep fibromatoses [1]. They constitute 3% of all soft tissue
tumors and 0.03% of all neoplasms [2]. Despite their
aggressive local infiltration, desmoid tumors lack a meta-
static potential [3]. However, because of this local infiltra-
tion and compression of surrounding structures, a high
recurrence rate exists and in anatomic locations with
restricted access to surgical resection desmoid tumors can
lead to death [4]. Especially in patients with familial ade-
nomatous polyposis (FAP) undergoing colectomy
desmoid tumors are the leading cause of morbidity and
mortality [5].
Molecular studies demonstrated desmoid tumors in FAP
as clonal neoplasms arising from germline mutation or
changes in the APC alleles [6–8]. Cytogenic data verified
clonal chromosome aberrations in deep-seated sporadic
extra-abdominal fibromatoses and lesions of the abdom-
inal wall and therefore provide additional evidence for the
neoplastic nature of these lesions [9].
Main locations of desmoid tumor occurrence are the prox-
imal extremities, the abdominal wall and the mesenteric
intestine in patients with FAP [10]. In sporadic cases, they
occur in localisations of trauma, and scars or irradiation.




A 28-year-old female recognized a left lower abdominal
wall tumor. In her history she reported an appendectomy
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1999. On clinical admission, a painless tumor was inves-
tigated without any contact to hip bone structures. Ana-
lysed blood parameters were within normal range and
tumor markers were negative.
Preoperative computed tomography scan (CT, figure 1)
and magnet-resonance-tomography (MRT, figure 2)
revealed a left lower abdominal wall tumor of unknown
dignity. The MRT morphology demonstrated a fibrotic
tumor, originating from the transversal and internal
oblique abdominal muscle fascia. The resection of the
tumor with excision of the oblique internal abdominal
muscle followed and the defect was covered with a Bard
Composix-Mesh® (C. R. Bard, Inc., 730 Central Aves Mur-
ray Hill, New Jersey, 07974, USA) and major omentum.
The postoperative course was uneventful and the patient
was discharged at the 8th postoperative day.
Case 2
A 37-year-old female recognized an initially painless
tumor in the right lower abdominal wall. In her history,
the patient reported on a laparoscopic resection of an
ovarian-cyst in 1993 and two pregnancies (1995 and
1997) with caesarean section. On admission, a palpable
demarcated fixed tumor in the right lower third of the lat-
eral abdominal wall was investigated. Analysed blood
parameters were within normal range and tumor markers
negative.
The CT revealed an ovarian-tumor, combined with a right
abdominal wall tumor of unknown dignity. A metastasis
of the ovarian-tumor, a lymphoma or a sarcoma was dis-
cussed as differential diagnosis. The MRT demonstrated
the abdominal wall tumor originating from the
abdominal transversal muscle and internal abdominal
oblique muscle fascia. First, extirpation of the right ovary
was performed. The resection of the abdominal wall
CT Scan with contrast enhancement demonstrates the desmoid tumor originating from the abdominal transversal and internal oblique muscle fasci  with inho ogeneous formation (arrow bar)Figur 1
CT Scan with contrast enhancement demonstrates the desmoid tumor originating from the abdominal transversal and internal 
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oblique muscle, replaced by a Bard Composix-Mesh® and
covered with major omentum.
The postoperative course was uneventful and the patient
was discharged at the 9th postoperative day.
Histological examination Case 1 and 2
Microscopic examination of the resected specimen in
both the cases revealed the spindle-cellular tumors immi-
grated through muscle-tissues consisting of partially intact
musclefibers surrounded by spindle like elements.
Tumor-cells had a pale eosinophilic cytoplasm and chro-
matin structures and were embedded in collagen network
interrupted by fibrotic sections (Figure 3). The immuno-
histochemistry revealed a minority of spindled tumor
cells, expressing smooth muscle cell actin. Lower than 3%
of the tumor-cells expressed the proliferative Ki 67 anti-
gen. A desmoid tumor was diagnosed in both cases (figure
4).
Sections from the ovary in case 2 revealed a demarcated,
non capsulated, spindle-cellular, collagen rich tumor a
diagnosis of an ovarian fibroma without signs of malig-
nancy was made.
Discussion
Desmoid tumors are benign deep fibromatoses, originat-
ing from fascia and muscle aponeurosis with an infiltrat-
ing growth [11]. They are primary located abdominally or
intraabdominally [1], whereas only sporadic cases
describe a localisation within the thorax wall [12] or ret-
roperitoneally [13]. The desmoid tumor is often associ-
ated with female gender, FAP [14] and occasionally with
surgical trauma [15]. It has a higher prevalence in women
who experienced pregnancy [16]. Depending on the
MRT shows the tumor's location embedded in the adjacent musculatureFigure 2
MRT shows the tumor's location embedded in the adjacent musculature. The hypointense parts of the tumor indicate the high 
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margins, recurrence occurs in up to 45% [17].
CT scan localizes the tumor and excludes metastasis (fig-
ure 1). MRT reveals the tumor's hypointensity on T1 and
demonstrates variable signal intensity on T2 weighted
imaging, depending on the accumulation of mucoid
structures (figure 2). Therefore, a differentiation from
other solid tumors is impossible using morphological cri-
teria [18]. Histology is the only evidentiary method which
demonstrates long fascicles of spindle cells of variable
cell-density with few mitoses and absence of atypical
nucleus-separations (figure 3). Characteristically, there is
a diffuse cell infiltration of adjacent tissue structures.
Immunohistochemical response for actin can be partially
positive and immunohistochemical muscle cell markers
delimit desmoid tumors from fibrosarcoma [19].
The therapy of choice is still controversial [20]. Anti-
inflammatory treatment [21], hormone-therapy [22] and
chemotherapy [23] were not shown to be effective. These
therapies are limited to patients, in whom resection is
technically impossible because of a widespread tumor
infiltration.
The effectiveness and indication of initial and adjuvant
radiation is not proven yet. In a comparative analysis, a
significantly better local recurrence control was described
with radiation and combined surgical resection in com-
parison to resection only [17]. However, these results of
radiation therapy can only be achieved due to a higher
complication rate [24]. Other studies show a tumor
progress after radiation therapy [25] and a high local
recurrence rate [26].
Due to the germline mutations and chromosomal aberra-
tions of the APC alleles Bright-Thomas et al. performed a
pre-clinical study of gene transfer for the treatment of
desmoid disease in FAP [27]. Despite the success of
transgene expression, further work is needed in animal
models of desmoid disease to assess the clinical effects of
gene therapy.
Therefore, the most effective treatment of accessible and
smaller desmoid tumors is still the resection with negative
margins, although it may not prevent local recurrence [4].
However, massive mesenteric lesions often occur in FAP
patients after colectomy [5] and non surgical treatment
has variable and unpredictable objective efficacy
[10,21,28,29]. Middleton et al. reported on successful
short-term surgery in four cases of large intra-abdominal
tumors in which non-surgical treatment was inefficient
[28]. In conclusion, there remains a need for a wider range
of therapeutic options, especially in the management of
these massive tumors.
Surgery always aims at radical tumor resection with free
margins, which, depending on localisation of surgery,
may leave major soft tissue defects behind [28,30,31].
Although abdominal wall integrity after full-thickness sur-
gery can be restored with direct sutures [4,32], reconstruc-
tion with synthetic materials is a common technique in
major abdominal wall defects [33]. Albeit in our study the
small tumor resection with tumor free margins and recon-
struction of the abdominal wall was performed with a
Bard Composix-Mesh® (figure 5), recent literature data
recommend distant or free muscle flaps for greater
abdominal wall defect coverage that is not accessible to
local flaps [30,32]. Additionally, prosthetic material is
more susceptible to bacterial infection and other compli-
cations [34,35], although new developed material
showed encouraging experimental results [36].
Layers of tumor cells with pale eosinophilic cytoplasm and nuclei and sporadic mitoses characterize the histologic l pictureFig  3
Layers of tumor cells with pale eosinophilic cytoplasm and 
nuclei and sporadic mitoses characterize the histological 
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World Journal of Surgical Oncology 2003, 1 http://www.wjso.com/content/1/1/11In conclusion, the treatment of desmoid tumors remains
enigmatic. Non-surgical treatment resulted in diverse and
unpredictable outcome and is considered to be an oppor-
tunity in patients with unresectable lesions or for adjuvant
therapy. Radical resection with clear margins remains the
principal determinant of outcome with the risk of local
recurrence.
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The desmoid tumor is macroscopically composed of a well-defined capsule infiltrated by a collagen network with fibrotic sectionFigur  4
The desmoid tumor is macroscopically composed of a well-defined capsule infiltrated by a collagen network with fibrotic 
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